Skip to content

The impact on the sensitivity of the method of removing suicidal thoughts

Study The Efficacy of Eye Movements Desensitization and Reprocessing on the Severity of Suicidal Thoughts in patients with major depressive disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171231038152N1
Enrollment
70
Registered
2018-09-16
Start date
2018-01-10
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder, suicidal thoughts. Major depressive disorder, single episode, severe with psychotic features

Interventions

Intervention 1: "Intervention group": In order to intervene in the intervention group, the researcher initially acquainted the patient with an eye-de-dysmotilator and re-treatment and familiarity with

Sponsors

Fasa University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 63 Years

Inclusion criteria

Inclusion criteria: , the diagnostic criteria for major depressive disorder has on the basis of the scale of the DSM-IV and has suicidal thoughts suicidal thoughts based on ascale, Beck Patients do not have a history of suicide Strabismus is vision problems will not be A history of febrile seizure will not be The age range is between twenty and sixty years

Exclusion criteria

Exclusion criteria: The patient is unable to tolerate the eye with movements sensitivity therapy tool and process again Sending patients to other medical centers, do not complete the treatment sessions

Design outcomes

Primary

MeasureTime frame
Suicide thought. Timepoint: The intensity of suicidal thoughts in the first session and three weeks later at the latest meeting of the measure to be. Method of measurement: beck suicide scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJahanfar Abdolhadi

Fasa University of Medical Sciences

jahanfarhadi91@gmail.com+98 74 3322 0162

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026